Semaglutide, marketed as Ozempic, recently became the first glucagon-like peptide 1 (GLP-1) receptor agonist approved by the US Food and Drug Administration (FDA) to reduce the risk of worsening kidney disease, kidney failure, and death due to cardiovascular disease in adults with type 2 diabetes (T2D) and chronic kidney disease (CKD), a common complication of T2D.
Risultati per: FDA approva una pillola contro la depressione a effetto rapido
Questo è quello che abbiamo trovato per te
Un'app terapista che aiuta chi soffre di ansia e depressione
Test clinici la promuovono. L’esperto: ‘Mai come sostitutivo del medico’
Melanoma e tumore del polmone, Aifa approva l'immunoterapia in fase precoce
Ok alla rimborsabilità negli stadi iniziali della malattia, può aumentare le guarigioni
Sostanze neurotossiche legate alla depressione nelle adolescenti
Più comuni in femmine, a scapito di sostanze neuroprotettive
FDA Issues Warning of Guillain-Barré Syndrome Risk for 2 RSV Vaccines
The respiratory syncytial virus (RSV) vaccines marketed as Abrysvo by Pfizer and Arexvy by GSK will now require a warning about the risk of Guillain-Barré syndrome (GBS), the US Food and Drug Administration (FDA) announced recently.
FDA Authorizes Marketing of ZYN Nicotine Pouch Products
The US Food and Drug Administration (FDA) recently authorized the marketing of 20 ZYN nicotine pouch products, the first of their kind to receive such approval. The decision followed an extensive scientific review that concluded that the benefits of these cigarette alternatives outweighed the risks, in line with the public health standards set by the 2009 Family Smoking Prevention and Tobacco Control Act.
Riconoscere batteri patogeni in modo più rapido ed efficace
Collaborazione tra SISSA e Alifax sviluppa nuova tecnica
Riconoscere batteri patogeni in modo più rapido ed efficace
Collaborazione tra SISSA e Alifax sviluppa nuova tecnica
Le donne più a rischio ansia e depressione, ma gli studi ignorano il genere
Gli esperti, ‘anche i medici responsabili, colmare il divario’
FDA Approves Generic Liraglutide to Address GLP-1 Drug Shortage
The US Food and Drug Administration (FDA) recently approved liraglutide to treat type 2 diabetes in combination with diet and exercise, which makes it the first generic version of Victoza and the second glucagon-like peptide-1 (GLP-1) receptor agonist authorized as a generic drug.
What’s Next for Nicotine? The Coming Legal and Political Battles over an FDA Proposal
New England Journal of Medicine, Ahead of Print.
FDA’s “Healthy” Food Rule Updated for First Time in 30 Years
Grocery items marketed as “healthy” will soon need to meet a new US Food and Drug Administration (FDA) rule that now focuses on whole foods.
FDA Approves Tirzepatide as First Drug for Obstructive Sleep Apnea
The US Food and Drug Administration (FDA) recently approved tirzepatide, marketed as Zepbound, for moderate to severe obstructive sleep apnea (OSA) in adults with obesity, making it the first sleep apnea drug, according to an agency press release.
La depressione riduce la sopravvivenza dei pazienti oncologici
Al via la piattaforma online di psiconcologia ‘In buona salute’
Depressione riduce la sopravvivenza dei pazienti oncologici
Al via la piattaforma online di psiconcologia ‘In buona salute’
FDA Guidance on Pulse Oximetry Testing Among Diverse Individuals
This study examines temporal trends in US Food and Drug Administration clearance summaries for pulse oximeters that report information about race and ethnicity and/or skin color or tone.